Federal Circuit Affirms Aventis' Inequitable Conduct
A federal appeals court has affirmed a lower court ruling that found Sanofi-Aventis' patents for its anti-clotting drug Lovenox invalid due to inequitable conduct, allowing generic versions of the drug to...To view the full article, register now.
Already a subscriber? Click here to view full article